$KALA Kala Pharmaceuticals, Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Kala Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Kala Pharmaceuticals, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Kala Pharmaceuticals, Inc. for free.
IRS Number: 270604595
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: KALA
Company Address: 490 ARSENAL WAY SUITE 120 WATERTOWN 02472
Phone number: 781-996-5252
Former name: Hanes Newco, Inc.
Kala Pharmaceuticals, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 21 2021 | KALA | Kala Pharmaceutica ... | Shah Rajeev M. | Grant | A | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K | |
| Jun 21 2021 | KALA | Kala Pharmaceutica ... | PERRY GREGORY D | Grant | A | 0.00 | 20,000 | 0 | 40,000 | 20 K to 40 K (+100.00 %) | |
| Jun 21 2021 | KALA | Kala Pharmaceutica ... | Grunberg Gregory | Grant | A | 0.00 | 20,000 | 0 | 40,000 | 20 K to 40 K (+100.00 %) | |
| Mar 03 2021 | KALA | Kala Pharmaceutica ... | Chen Hongming | Chief Scientific Of ... | Option Exercise | M | 2.30 | 9,500 | 21,850 | 53,736 | |
| Mar 03 2021 | KALA | Kala Pharmaceutica ... | Chen Hongming | Chief Scientific Of ... | Buy | M | 2.30 | 9,500 | 21,850 | 243,015 | 233.5 K to 243 K (+4.07 %) |
| Feb 26 2021 | KALA | Kala Pharmaceutica ... | Chen Hongming | Chief Scientific Of ... | Option Exercise | M | 2.30 | 47,000 | 108,100 | 63,236 | |
| Feb 26 2021 | KALA | Kala Pharmaceutica ... | Chen Hongming | Chief Scientific Of ... | Buy | M | 2.30 | 47,000 | 108,100 | 233,515 | 186.5 K to 233.5 K (+25.20 %) |
| Jan 05 2021 | KALA | Kala Pharmaceutica ... | Chen Hongming | Chief Scientific Of ... | Option Exercise | A | 6.86 | 90,667 | 621,976 | 90,667 | |
| Jan 05 2021 | KALA | Kala Pharmaceutica ... | Chen Hongming | Chief Scientific Of ... | Grant | A | 0.00 | 22,666 | 0 | 186,515 | 163.8 K to 186.5 K (+13.83 %) |
| Jan 05 2021 | KALA | Kala Pharmaceutica ... | Bazemore Todd | Chief Operating Off ... | Option Exercise | A | 6.86 | 110,000 | 754,600 | 110,000 | |
| Jan 05 2021 | KALA | Kala Pharmaceutica ... | Bazemore Todd | Chief Operating Off ... | Option Exercise | A | 6.86 | 110,000 | 754,600 | 110,000 | |
| Jan 05 2021 | KALA | Kala Pharmaceutica ... | Bazemore Todd | Chief Operating Off ... | Grant | A | 0.00 | 27,500 | 0 | 137,500 | 110 K to 137.5 K (+25.00 %) |
| Jan 05 2021 | KALA | Kala Pharmaceutica ... | Bazemore Todd | Chief Operating Off ... | Grant | A | 0.00 | 27,500 | 0 | 137,500 | 110 K to 137.5 K (+25.00 %) |
| Jan 05 2021 | KALA | Kala Pharmaceutica ... | Reumuth Mary | Chief Financial Off ... | Option Exercise | A | 6.86 | 90,667 | 621,976 | 90,667 | |
| Jan 05 2021 | KALA | Kala Pharmaceutica ... | Reumuth Mary | Chief Financial Off ... | Grant | A | 0.00 | 22,666 | 0 | 147,959 | 125.3 K to 148 K (+18.09 %) |